131 related articles for article (PubMed ID: 6966069)
1. Long-term influence of splenectomy on immune functions in patients with Hodgkin's disease.
Björkholm M; Askergren J; Holm G; Mellstedt H
Scand J Haematol; 1980 Jan; 24(1):87-94. PubMed ID: 6966069
[TBL] [Abstract][Full Text] [Related]
2. [Long term effects of splenectomy on the immune-status of Hodgkin's disease patients depending on the modality of treatment (author's transl)].
Schaadt M; Diehl V; Kalden JR; Schmidt N; Laskewitz E
Med Klin; 1978 Oct; 73(40):1381-8. PubMed ID: 309061
[TBL] [Abstract][Full Text] [Related]
3. Persisting lymphocyte deficiences during remission in Hodgkin's disease.
Björkholm M; Holm G; Mellstedt H
Clin Exp Immunol; 1977 Jun; 28(3):389-93. PubMed ID: 302164
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal studies of blood lymphocyte capacity in Hodgkin's disease.
Björkholm M; Wedelin C; Holm G; Johansson B; Mellstedt H
Cancer; 1981 Nov; 48(9):2010-5. PubMed ID: 7296509
[TBL] [Abstract][Full Text] [Related]
5. Serum immunoglobulin levels in splenectomized Hodgkin patients and in subjects following post-traumatic splenectomy.
Douer D; Chaimoff C; Pick AI; Pinkhas J
Oncology; 1981; 38(3):165-7. PubMed ID: 7207953
[TBL] [Abstract][Full Text] [Related]
6. [Proportions and absolute count of T- and B-lymphocytes in peripheral blood and their blastic transformation induced by mitogens in splenectomized and non-splenectomized patients with Hodgkin's disease].
Pluzańska A
Acta Haematol Pol; 1978; 9(1):37-44. PubMed ID: 307325
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of the changes in immune status following radiotherapy for Hodgkin's disease.
van Rijswijk RE; Sybesma JP; Kater L
Cancer; 1984 Jan; 53(1):62-9. PubMed ID: 6690004
[TBL] [Abstract][Full Text] [Related]
8. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
Steele R; Han T
Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
[TBL] [Abstract][Full Text] [Related]
9. Changes in immune status in patients undergoing splenectomy for the staging of Hodgkin's disease.
Hancock BW; Bruce L; Ward AM; Richmond J
Br Med J; 1976 Feb; 1(6005):313-5. PubMed ID: 1247837
[TBL] [Abstract][Full Text] [Related]
10. Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
Romagnani S; Del Prete GF; Maggi E; Bellesi G; Biti G; Rossi Ferrini PL; Ricci M
J Clin Invest; 1983 May; 71(5):1375-82. PubMed ID: 6602150
[TBL] [Abstract][Full Text] [Related]
11. Immunologic impairment after long-term remission in splenectomized patients with Hodgkin's disease.
Loven D; Pick AI; Weiss H; Duczyminer-Kahana M; Lurie H
Acta Oncol; 1991; 30(6):763-5. PubMed ID: 1958399
[No Abstract] [Full Text] [Related]
12. Immunological defects in healthy twin siblings to patients with Hodgkin's disease.
Björkholm M; Holm G; De Faire U; Mellsted H
Scand J Haematol; 1977 Oct; 19(4):396-404. PubMed ID: 562530
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte counts and functions in arterial and venous splenic blood of patients with Hodgkin's disease. Evidence for elimination of spontaneously DNA synthesizing cells in the spleen.
Björkholm M; Holm G; Askergren J; Mellstedt H
Clin Exp Immunol; 1983 Jun; 52(3):485-92. PubMed ID: 6872314
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in Hodgkin's disease. II. Role of the lymphocyte defect.
Björkholm M; Holm G; Mellstedt H; Johansson B; Killander D; Sunblad R; Söderberg G
Scand J Haematol; 1978 Apr; 20(4):306-18. PubMed ID: 653310
[TBL] [Abstract][Full Text] [Related]
15. Immunity in Hodgkin's disease: status after 5 years' remission.
Hancock BW; Bruce L; Whitham MD; Dunsmore IR; Ward AM; Richmond J
Br J Cancer; 1982 Oct; 46(4):593-600. PubMed ID: 7138765
[TBL] [Abstract][Full Text] [Related]
16. The influence of splenectomy on cellular immunologic parameters in Hodgkin's disease.
Wagener DJ; Geestman E; Borgonjen A; Haanen C
Cancer; 1976 May; 37(5):2212-9. PubMed ID: 130968
[TBL] [Abstract][Full Text] [Related]
17. Increase of T lymphocytes in the spleen in Hodgkin's disease.
Kaur J; Spiers AS; Catovsky D; Galton DA
Lancet; 1974 Oct; 2(7884):800-2. PubMed ID: 4138221
[No Abstract] [Full Text] [Related]
18. Serum immunoglobulin levels in childhood Hodgkin's disease. Effect of splenectomy and long-term follow-up.
Walzer PD; Armstrong D; Weisman P; Tan C
Cancer; 1980 Apr; 45(8):2084-9. PubMed ID: 7370954
[TBL] [Abstract][Full Text] [Related]
19. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.
Fuks Z; Strober S; Bobrove AM; Sasazuki T; McMichael A; Kaplan HS
J Clin Invest; 1976 Oct; 58(4):803-14. PubMed ID: 135001
[TBL] [Abstract][Full Text] [Related]
20. Immune status of untreated patients with Hodgkin's disease and prognosis.
Björkholm M; Wedelin C; Holm G; Ogenstad S; Johansson B; Mellstedt H
Cancer Treat Rep; 1982 Apr; 66(4):701-9. PubMed ID: 7074640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
